Nutex Health Inc. (NUTX)
NASDAQ: NUTX · Real-Time Price · USD
122.90
+4.44 (3.75%)
Jun 27, 2025, 4:00 PM - Market closed
Nutex Health Stock Forecast
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for Nutex Health stock ranges from a low of $225 to a high of $300. The average analyst price target of $262.5 forecasts a 113.59% increase in the stock price over the next year.
Price Target: $262.50 (+113.59%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 20, 2025.
Analyst Ratings
The average analyst rating for Nutex Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $100 → $225 | Strong Buy | Maintains | $100 → $225 | +83.08% | May 20, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $150 → $300 | Strong Buy | Maintains | $150 → $300 | +144.10% | May 15, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $75 → $100 | Strong Buy | Maintains | $75 → $100 | -18.63% | Apr 8, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $50 → $75 | Strong Buy | Maintains | $50 → $75 | -38.97% | Feb 13, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $45 → $50 | Strong Buy | Maintains | $45 → $50 | -59.32% | Nov 12, 2024 |
Financial Forecast
Revenue This Year
795.83M
from 479.95M
Increased by 65.82%
Revenue Next Year
835.48M
from 795.83M
Increased by 4.98%
EPS This Year
10.81
from 9.71
Increased by 11.35%
EPS Next Year
8.18
from 10.81
Decreased by -24.34%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 851.6M | 909.3M |
| Avg | 795.8M | 835.5M |
| Low | 734.5M | 756.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 77.4% | 14.3% |
| Avg | 65.8% | 5.0% |
| Low | 53.0% | -4.9% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | 11.13 | 8.42 |
| Avg | 10.81 | 8.18 |
| Low | 10.39 | 7.86 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | 14.6% | -22.1% |
| Avg | 11.3% | -24.3% |
| Low | 7.0% | -27.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.